Literature DB >> 33546471

Power Failure of Mitochondria and Oxidative Stress in Neurodegeneration and Its Computational Models.

JunHyuk Woo1,2, Hyesun Cho1, YunHee Seol1, Soon Ho Kim1, Chanhyeok Park1, Ali Yousefian-Jazi1, Seung Jae Hyeon1, Junghee Lee3,4, Hoon Ryu1,3.   

Abstract

The brain needs more energy than other organs in the body. Mitochondria are the generator of vital power in the living organism. Not only do mitochondria sense signals from the outside of a cell, but they also orchestrate the cascade of subcellular events by supplying adenosine-5'-triphosphate (ATP), the biochemical energy. It is known that impaired mitochondrial function and oxidative stress contribute or lead to neuronal damage and degeneration of the brain. This mini-review focuses on addressing how mitochondrial dysfunction and oxidative stress are associated with the pathogenesis of neurodegenerative disorders including Alzheimer's disease, amyotrophic lateral sclerosis, Huntington's disease, and Parkinson's disease. In addition, we discuss state-of-the-art computational models of mitochondrial functions in relation to oxidative stress and neurodegeneration. Together, a better understanding of brain disease-specific mitochondrial dysfunction and oxidative stress can pave the way to developing antioxidant therapeutic strategies to ameliorate neuronal activity and prevent neurodegeneration.

Entities:  

Keywords:  Alzheimer’s disease; Huntington’s disease; Parkinson’s disease; amyotrophic lateral sclerosis; antioxidants; computational modeling; mitochondria; oxidative stress

Year:  2021        PMID: 33546471      PMCID: PMC7913624          DOI: 10.3390/antiox10020229

Source DB:  PubMed          Journal:  Antioxidants (Basel)        ISSN: 2076-3921


  173 in total

1.  The free-radical theory of ageing--older, wiser and still alive: modelling positional effects of the primary targets of ROS reveals new support.

Authors:  Thomas B L Kirkwood; Axel Kowald
Journal:  Bioessays       Date:  2012-05-29       Impact factor: 4.345

2.  Mitochondrial mutations, cellular instability and ageing: modelling the population dynamics of mitochondria.

Authors:  A Kowald; T B Kirkwood
Journal:  Mutat Res       Date:  1993-08       Impact factor: 2.433

3.  Thermodynamics and control of proton motive free-energy transduction.

Authors:  H V Westerhoff
Journal:  Biomed Biochim Acta       Date:  1985

4.  Inducible nitric oxide synthase up-regulation in a transgenic mouse model of familial amyotrophic lateral sclerosis.

Authors:  G Almer; S Vukosavic; N Romero; S Przedborski
Journal:  J Neurochem       Date:  1999-06       Impact factor: 5.372

Review 5.  Astrocytes: biology and pathology.

Authors:  Michael V Sofroniew; Harry V Vinters
Journal:  Acta Neuropathol       Date:  2009-12-10       Impact factor: 17.088

Review 6.  The failure of mitochondria leads to neurodegeneration: Do mitochondria need a jump start?

Authors:  Junghee Lee; Jung Hyun Boo; Hoon Ryu
Journal:  Adv Drug Deliv Rev       Date:  2009-08-27       Impact factor: 15.470

Review 7.  Mitochondrial ATP synthase: architecture, function and pathology.

Authors:  An I Jonckheere; Jan A M Smeitink; Richard J T Rodenburg
Journal:  J Inherit Metab Dis       Date:  2011-08-27       Impact factor: 4.982

8.  Mitochondria-specific accumulation of amyloid β induces mitochondrial dysfunction leading to apoptotic cell death.

Authors:  Moon-Yong Cha; Sun-Ho Han; Sung Min Son; Hyun-Seok Hong; Young-Ju Choi; Jayoung Byun; Inhee Mook-Jung
Journal:  PLoS One       Date:  2012-04-13       Impact factor: 3.240

9.  Quantitative profiling brain proteomes revealed mitochondrial dysfunction in Alzheimer's disease.

Authors:  Sunil S Adav; Jung Eun Park; Siu Kwan Sze
Journal:  Mol Brain       Date:  2019-01-28       Impact factor: 4.041

10.  Mathematical modeling of the role of mitochondrial fusion and fission in mitochondrial DNA maintenance.

Authors:  Zhi Yang Tam; Jan Gruber; Barry Halliwell; Rudiyanto Gunawan
Journal:  PLoS One       Date:  2013-10-11       Impact factor: 3.240

View more
  6 in total

Review 1.  Molecular Pathophysiological Mechanisms in Huntington's Disease.

Authors:  Anamaria Jurcau
Journal:  Biomedicines       Date:  2022-06-17

2.  Antioxidant Role and Cardiolipin Remodeling by Redox-Activated Mitochondrial Ca2+-Independent Phospholipase A2γ in the Brain.

Authors:  Pavla Průchová; Klára Gotvaldová; Katarína Smolková; Lukáš Alán; Blanka Holendová; Jan Tauber; Alexander Galkin; Petr Ježek; Martin Jabůrek
Journal:  Antioxidants (Basel)       Date:  2022-01-20

3.  Peripheral Neuroprotective and Immunomodulatory Effects of 5α-Reductase Inhibitors in Parkinson's Disease Models.

Authors:  Andrée-Anne Poirier; Mélissa Côté; Hend Jarras; Nadhir Litim; Jérôme Lamontagne-Proulx; Sara Al-Sweidi; Marc Morissette; Asmaa Lachhab; Martin Pelletier; Thérèse Di Paolo; Denis Soulet
Journal:  Front Pharmacol       Date:  2022-07-22       Impact factor: 5.988

Review 4.  Therapeutic Strategies in Huntington's Disease: From Genetic Defect to Gene Therapy.

Authors:  Anamaria Jurcau; Maria Carolina Jurcau
Journal:  Biomedicines       Date:  2022-08-05

5.  Oxidative Stress Biomarkers and Mitochondrial DNA Copy Number Associated with APOE4 Allele and Cholinesterase Inhibitor Therapy in Patients with Alzheimer's Disease.

Authors:  Chia-Wei Liou; Shih-Hsuan Chen; Tsu-Kung Lin; Meng-Han Tsai; Chiung-Chih Chang
Journal:  Antioxidants (Basel)       Date:  2021-12-10

Review 6.  Nanotechnology-Based Drug Delivery Strategies to Repair the Mitochondrial Function in Neuroinflammatory and Neurodegenerative Diseases.

Authors:  Luis F González; Lorenzo E Bevilacqua; Rodrigo Naves
Journal:  Pharmaceutics       Date:  2021-12-01       Impact factor: 6.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.